1
Name
1 Name
(1) This instrument is the National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019. (2) This instrument may also be cited as PB 113 of 2019.
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Commonwealth legislation
This determination sets how the retail price for a pharmaceutical benefit is calculated under subsection 84C(7) of the National Health Act 1953. It requires adding the Commonwealth price (per PB 66 of 2020), any additional patient charge, and a fixed dispensing amount — $1.48 for ready‑prepared items or $1.91 for extemporaneously‑prepared items (s 6(1)). The calculated price is subject to an upper limit: it cannot exceed the maximum an approved pharmacist may charge under ss 87(2)–(3) (s 6(2)).
Want the full deep dive?
Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.
Direct links to the current provisions in National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019.
(1) This instrument is the National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019. (2) This instrument may also be cited as PB 113 of 2019.
This instrument is made under subsection 84C(7) of the National Health Act 1953.
In this instrument:
Act means the National Health Act 1953.
additional patient charge has the same meaning as in the National Health (Pharmaceutical Benefits) Regulations 2017.
approved pharmacist has the meaning given by subsection 84(1) of the Act.
extemporaneously‑prepared pharmaceutical benefit means a pharmaceutical benefit that is not a ready‑prepared pharmaceutical benefit.
pharmaceutical benefit has the meaning given by subsection 84(1) of the Act.
ready‑prepared pharmaceutical benefit means a brand of a pharmaceutical item determined under subsection 85(6) of the Act.
(1) For the purposes of subsection 84C(7) of the Act, the price for a pharmaceutical benefit (of a particular quantity or number of units) is to be ascertained by adding: (a) the Commonwealth price for the supply of the benefit by an approved pharmacist, worked out in accordance with the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020); and (b) the amount of the additional patient charge; and (c) either: (i) if the pharmaceutical benefit is a ready‑prepared pharmaceutical benefit—$1.48; or (ii) if the pharmaceutical benefit is an extemporaneously‑prepared pharmaceutical benefit—$1.91.
Note: This subsection complies with subsection 84C(8) of the Act because, to comply with subsection 98B(2) of the Act, the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020):
(a) uses as a basis the approved ex‑manufacturer price, a proportional ex‑manufacturer price or the basic wholesale price; and
(b) provides for the addition of other fees and amounts determined by the Tribunal that made the determination.
(2) However, the price for the pharmaceutical benefit must not be more than the amount that an approved pharmacist may charge for the supply of the benefit under subsection 87(2) or (3) of the Act.
Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.
(1) This instrument is the National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019. (2) This instrument may also be cited as PB 113 of 2019.
This instrument is made under subsection 84C(7) of the National Health Act 1953.
In this instrument:
Act means the National Health Act 1953.
additional patient charge has the same meaning as in the National Health (Pharmaceutical Benefits) Regulations 2017.
approved pharmacist has the meaning given by subsection 84(1) of the Act.
extemporaneously‑prepared pharmaceutical benefit means a pharmaceutical benefit that is not a ready‑prepared pharmaceutical benefit.
pharmaceutical benefit has the meaning given by subsection 84(1) of the Act.
ready‑prepared pharmaceutical benefit means a brand of a pharmaceutical item determined under subsection 85(6) of the Act.
(1) For the purposes of subsection 84C(7) of the Act, the price for a pharmaceutical benefit (of a particular quantity or number of units) is to be ascertained by adding: (a) the Commonwealth price for the supply of the benefit by an approved pharmacist, worked out in accordance with the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020); and (b) the amount of the additional patient charge; and (c) either: (i) if the pharmaceutical benefit is a ready‑prepared pharmaceutical benefit—$1.48; or (ii) if the pharmaceutical benefit is an extemporaneously‑prepared pharmaceutical benefit—$1.91.
Note: This subsection complies with subsection 84C(8) of the Act because, to comply with subsection 98B(2) of the Act, the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020):
(a) uses as a basis the approved ex‑manufacturer price, a proportional ex‑manufacturer price or the basic wholesale price; and
(b) provides for the addition of other fees and amounts determined by the Tribunal that made the determination.
(2) However, the price for the pharmaceutical benefit must not be more than the amount that an approved pharmacist may charge for the supply of the benefit under subsection 87(2) or (3) of the Act.